Fever - Useful or noxious symptom that should be treated?;Fieber - Nützliches oder schädliches, zu behandelndes symptom?

Therapeutische Umschau

Volumn 63, Issue 3, 2006, Pages 185-188

  Schaffner, A ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b NONE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPYRETIC AGENT; ANTIRHEUMATIC AGENT; IBUPROFEN; NONSTEROIDAL ANTIRHEUMATIC AGENT; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BRAIN INJURY; CONVULSION; DEMENTIA; FEVER; HEART FAILURE; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INTENSIVE CARE; METABOLIC RATE; PROGNOSIS; RESPIRATORY FAILURE; SEPSIS; STROKE; THERMOGENESIS; THERMOREGULATION;

ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEVER; HUMANS; IMMUNITY, NATURAL; INFECTION; INTENSIVE CARE; SEPSIS;

EID: 33645108424     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.63.3.185     Document Type: Article

References (10)

1. Kluger MJ, Kozak W, Conn CA, Leon LR, Soszynski D. Role of fever in disease. Ann N Y Acad Sci 1998; 856: 224-33.
2. Bouchama A, Knochel JP. Heat stroke. N Engl J Med 2002; 346(25): 1978-88.
3. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002; 346(8): 549-56.
4. Greisman LA, Mackowiak PA. Fever: beneficial and detrimental effects of antipyretics. Curr Opin Infect Dis 2002; 15(3): 241-5.
5. Mackowiak PA, Plaisance KI. Benefits and risks of antipyretic ABEtherapy. Ann N Y Acad Sci 1998; 856: 214-23.
6. Kluger MJ, Kozak W, Conn CA, Leon LR, Soszynski D. Role of fever in disease. Ann N Y Acad Sci 1998; 856: 224-33.
7. Jiang Q, Cross AS, Singh IS, Chen TT, Viscardi RM, Hasday JD. Febrile core temperature is essential for optimal host defense in bacterial peritonitis. Infect Immun 2000; 68(3): 1265-70.
8. Sobrado J, Moldawer LL, Bistrian BR, Dinarello CA, Blackburn GL. Effect of ibuprofen on fever and metabolic changes induced by continuous infusion of leukocytic pyrogen (interleukin 1) or endotoxin. Infect Immun 1983; 42(3): 997-1005.
9. Grebe W, Ionescou E, Gold MS, Liu JH, Frank WO. A multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled, parallel-group comparison of diclofenac-k and ibuprofen for the treatment of adults with influenza-like symptoms. Clin Ther 2003; 25(2): 444-58.
10. Bernard GR, Wheeler AP, Russell JA, Schein R, Summer WR, Steinberg KP et al. The Effects of Ibuprofen on the Physiology and Survival of Patients with Sepsis. N Engl J Med 1997; 336(13): 912-18.